Quarterly report pursuant to Section 13 or 15(d)

Equity - Summary of Option Activities (Details)

v3.8.0.1
Equity - Summary of Option Activities (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2017
Dec. 31, 2016
Number of Shares    
Number of shares outstanding, beginning of period 510,000  
Number of shares granted 160,000  
Number of shares outstanding, end of period 670,000 510,000
Number of shares exercisable, end of period 85,000  
Weighted Average Grant Date Fair Value    
Weighted average grant date fair value, outstanding, beginning of period (in dollars per share) $ 3.40  
Weighted average grant date fair value, granted (in dollars per share) 1.52  
Weighted average grant date fair value, outstanding, end of period (in dollars per share) 2.12 $ 3.40
Weighted average grant date fair value, exercisable (in dollars per share) 1.66  
Weighted Average Exercise Price    
Weighted average exercise price, outstanding balance (in dollars per share) 5.28  
Weighted average exercise price, granted (in dollars per share) 2.14  
Weighted average exercise price, outstanding balance (in dollars per share) 1.78 $ 5.28
Weighted average exercise price, exercisable (in dollars per share) $ 1.79  
Weighted average remaining contractual term (in years), outstanding 8 years 10 months 6 days 9 years 3 months 14 days
Weighted average remaining contractual term (in years), exercisable 7 years 1 month 24 days  
Aggregate intrinsic value, outstanding balance $ 144,900 $ 275,500
Aggregate intrinsic value, exercisable $ 117,300